Sign up for our daily Newsletter and stay up to date with all the latest news!

Subscribe I am already a subscriber

You are using software which is blocking our advertisements (adblocker).

As we provide the news for free, we are relying on revenues from our banners. So please disable your adblocker and reload the page to continue using this site.

Click here for a guide on disabling your adblocker.

Sign up for our daily Newsletter and stay up to date with all the latest news!

Subscribe I am already a subscriber

CO: Successful completion of flower samples testing

Canadian Imperial Venture has announced that Ikänik International, represented by its medical division in Colombia, Pideka, a wholly owned subsidiary of Ikänik Farms, has successfully completed a pesticide, heavy metal and microbiological testing of flower samples grown at Casa Flores, Ikänik’s state-of-the-art 80,000 sq. ft. cannabis camp located outside Bogota, Colombia, currently under construction.

“This is a major milestone for our dedicated team, propelling us into a unique position within the broader cannabis industry. We are excited to be the first company in Colombia to achieve results supporting a pharmaceutical grade cannabis product,” said Borja Sanz de Madrid, President of Ikänik International.

Testing was conducted by third party Ciconea in its ISO 9001 and ENAC accredited laboratory in Spain, reflected passing test scores in all flower samples provided by Pideka, according to them. "The successful testing for heavy metals, pesticide and microbiological supports the flower grown at Casa Flores in qualifying it as the first pharmaceutical grade cannabis flower to be legally produced in Colombia," the team with the company explains. "Cannabis materials which exceed the standardized heavy metals and pesticide limits are deemed non-pharmaceutical grade and are thus ineligible for pharmaceutical exportation into the European Union."

"After meeting all cannabis quality standards set forth by the Council of Europe, Ikänik aims to establish strategic development and distribution partnerships in the EU by Q3 2020. This assumes the construction schedule at the Casa Flores cannabis camp remains on schedule and budget and that Pideka will be able to source development and distribution partners and engage in legal relationships on favorable terms."

“The successful completion of testing through an EU laboratory, supports the sophistication implemented through the production processes and controls used at our Casa Flores cannabis camp,” said Brian Baca, CEO of Ikänik Farms.

Testing Methodology
Pideka provided samples of dried flower from multiple strains cultivated at Casa Flores. Testing was conducted at Ciconea’s ISO 9001 and ENAC accredited laboratory in order to measure for pesticides and heavy metals present in these samples. "The samples passed in all qualifying categories," they say. 

Additionally, a microbiological test was conducted to validate that the material was homogenous, with no systemic preclusions as set forth by European Pharmacopoeia, Europe’s legal and scientific benchmark for pharmacopoeia standards.

"The strains tested are intended for commercial production of medicinal cannabis at Casa Flores. Ikänik is pursuing GMP-C certification for the Casa Flores facility and will look to export pharmaceutical grade cannabis to international markets, namely Europe."

For more information:
Ikänik Farms    

Publication date: